Oncology-focused US biotech Polynoma, part of the Hong Kong company CK Life Sciences, has expanded its senior management team with three appointments: Dr Sara Zaknoen joins as chief medical officer, Andrew Buckland as chief financial officer and Patrick Mallon as chief operating officer. Dr Zaknoen joins from Tragara Pharmaceuticals where she was CMO; Mr Buckland most recently served as CFO of PURE Bioscience; and Mr Mallon was previously CEO at Genpathway having previously served at Roche, Gen-Probe and Agouron.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?